Pilot study tests repurposed pill for stubborn skin disease
Disease control
Recruiting now
This study is testing if an oral medication called roflumilast is safe and can help improve moderate-to-severe plaque psoriasis. For 12 weeks, 36 adult participants will take the pill daily. Researchers will measure changes in skin symptoms and monitor for side effects to see if …
Phase: PHASE2 • Sponsor: Ahmed Ibrahim • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC